A post-marketing surveillance program of the Food and Drug Administration (FDA) in which physicians report on the adverse effects of and product problems with drugs and other medical products after they have been put on the market.
A voluntary and confidential program of the Food and Drug Administration (FDA) for monitoring the safety of drugs, biologicals, medical devices, and nutritional products such as dietary supplements, medical foods, and infant formulas. The FDA provides forms for reporting adverse events associated with any of these products.